Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.53 |
| ▸ | FAAH | O00519 | 2/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4933994 | 1.00 | MAPT (0.68) | MAPTALDH1A1HCAR2FAAHATM | |
| SCHEMBL4582052 | 0.98 | MAPT (0.66) | MAPTALDH1A1HCAR2FAAHCYP3A4 | |
| SCHEMBL4940218 | 0.98 | MAPT (0.66) | MAPTALDH1A1HCAR2FAAHCYP3A4 | |
| SCHEMBL4582863 | 0.96 | MAPT (0.73) | MAPTALDH1A1HCAR2FAAHATM | |
| SCHEMBL4936379 | 0.96 | MAPT (0.73) | MAPTALDH1A1HCAR2FAAHATM | |
| SCHEMBL265418 | 0.92 | MAPT (0.66) | MAPTALDH1A1HCAR2ATMCYP3A4 | |
| SCHEMBL755909 | 0.92 | MAPT (0.66) | MAPTALDH1A1HCAR2ATMCYP3A4 | |
| SCHEMBL29430520 | 0.92 | MAPT (0.66) | MAPTALDH1A1HCAR2ATMCYP3A4 | |
| SCHEMBL4410945 | 0.91 | MAPT (0.66) | MAPTALDH1A1FAAHALOX15HSD17B10 | |
| SCHEMBL4410947 | 0.91 | MAPT (0.66) | MAPTALDH1A1FAAHALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080076699-A1 | Deconjugated alkadienoic acid esters as fragrances and or aroma substances | SYMRISE GMBH & CO. KG (DE) | 2008-03-27 | — | — | US | claimed |
| EP-1902632-A1 | Deconjugated alkadien acid esters as olefactory and or aroma substances | Symrise GmbH & Co. KG (DE) | 2008-03-26 | — | — | EP | claimed |
| US-20080076699-A1 | Deconjugated alkadienoic acid esters as fragrances and or aroma substances | SYMRISE GMBH & CO. KG (DE) | 2008-03-27 | — | — | US | disclosed |
| EP-1902632-A1 | Deconjugated alkadien acid esters as olefactory and or aroma substances | Symrise GmbH & Co. KG (DE) | 2008-03-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080076699-A1 | Deconjugated alkadienoic acid esters as fragrances and or aroma substances | DECR1, ALOX12, ALOX15 | MAPT 4488/4885ALDH1A1 21/4885HCAR2 108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.